The current position： Home>Technology

Technology
- 干細(xì)胞
- 免疫細(xì)胞

Translational medicine
- 干細(xì)胞治療
- 免疫細(xì)胞治療

Academic center

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged ... [more]

Technology

Effectiveness

For different diseases with different symptoms in varying degrees, JZB stem cell experts will provide you, based on your situation, a specific treatment plan with our experiences and international relevant reports, and the plan will be adjusted flexibly during the treatment. The situations of JZB clients after our stem cell treatments have been improved or cured in varying degrees.

上一篇：Safety

下一篇：A Transient Niche Regulates the Specification of Drosophila Intestinal Stem Cells

Hepatology Hospital
China-Japan Union Hospital
The Second Hospital
Hospital Jilin Province
The Third Hospital
The First Hospital

版權(quán)所有? 吉林省中科生物工程有限公司吉ICP備12000258號(hào)

欧美日韩精品,成人欧美一区二区三区视频不卡 ,高H粗口调教羞辱SM文女王动画,久久国产精品夜色

Effectiveness